Financial Instruments - Composition of Financial Instruments (Details) - USD ($) $ in Thousands |
Sep. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Fair Value Disclosures [Abstract] | ||
| Cost | $ 20,005 | $ 20,005 |
| Gains | 0 | 0 |
| Losses | (5,393) | (1,476) |
| Fair Value | 14,612 | $ 18,529 |
| Contingent consideration (Note 3) | $ 2,690 |
| X | ||||||||||
- Definition Equity Securities, Accumulated Net Unrealized Gain No definition available.
|
| X | ||||||||||
- Definition Equity Securities, Accumulated Net Unrealized Loss No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|